vincristine news

All news on vincristine (also known as leurocristine and Oncovin): plants, production capacities, investments and involved companies.

23 July 2026

Genmab and AbbVie clarify EPCORE DLBCL-1 US primary endpoint not met

The trial's sole U.S. primary endpoint—overall survival—did not reach statistical significance; additional results will be submitted for peer review.

Who will be producing vincristine in the future?

Find out with chemXplore

Learn more